Science Abstracts
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
March 2010
March 2010
Authors : Marianna Mazza1 , Maria Rosaria Squillacioti1 , Riccardo Daniele Pecora2 , Luigi Janiri1 , Pietro Bria1
Affliation :
1Catholic University of Sacred Heart of Rome, Institute of Psychiatry and Psychology, Bipolar Disorders Unit, Via Ugo De Carolis, 48 00136 Roma, Italy ; ; ; mariannamazza@hotmail.com
2Polo Ospedaliero SS. Trinità, Sora, ASL Frosinone, Italy
DOI : 10.1517/14656560802504490
Published in : Expert Opin. Pharmacother.
Subject: Original research
Keywords: aripiprazole , bipolar disorder , depression , open label
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- Dainippon Sumitomo's antipsychotic lurasidone positive in second Phase III study
- J&J's Invega is first drug approved for schizoaffective disorder in US
- US FDA advisory panel backs Salix's Xifaxan for hepatic encephalopathy
- Clinical Data's vilazodone succeeds in second Phase III trial
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
